Search
for

    Sort by

    Research

    570-600 / 1000+ results
      Pathology

      research Pathology

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.
      Cutaneous Drug Reaction Case Reports

      research Cutaneous Drug Reaction Case Reports

      January 2003 in “American Journal of Clinical Dermatology”
      In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.
      Potassium Channel Therapeutics at the Bedside

      research Potassium Channel Therapeutics at the Bedside

      119 citations, June 2005 in “Journal of Molecular and Cellular Cardiology”
      Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.
      Advances in Chitosan-Based Nanoparticles for Drug Delivery

      research Advances in Chitosan-Based Nanoparticles for Drug Delivery

      96 citations, September 2021 in “International Journal of Molecular Sciences”
      Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.
      Pediatric Tinea Capitis: Rising Incidence and Treatment

      research Pediatric Tinea Capitis: Rising Incidence and Treatment

      65 citations, January 2005 in “American journal of clinical dermatology”
      Children with scalp fungal infections need proper diagnosis and treatment, usually with antifungal medications, and newer drugs may offer quicker recovery.
      Hair Follicles as a Target Structure for Nanoparticles

      research Hair Follicles as a Target Structure for Nanoparticles

      59 citations, July 2015 in “Journal of innovative optical health sciences/Journal of innovation in optical health science”
      Nanoparticles around 600-700 nm can effectively enter and stay in hair follicles for days, which may help in delivering drugs to specific cells.
      Therapeutic Strategies for Treating Hair Loss

      research Therapeutic Strategies for Treating Hair Loss

      42 citations, March 2006 in “Drug Discovery Today: Therapeutic Strategies”
      The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.
      Management of Tinea Capitis in Childhood

      research Management of Tinea Capitis in Childhood

      38 citations, July 2010 in “Clinical, cosmetic and investigational dermatology”
      To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

      research Systemic Lupus Erythematosus

      23 citations, July 2015 in “Encyclopedia of Life Sciences”
      Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.
      Contraception and the Dermatologist

      research Contraception and the Dermatologist

      22 citations, January 2013 in “Journal of The American Academy of Dermatology”
      Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.
      Telogen Effluvium: Causes, Diagnosis, and Treatments

      research Telogen Effluvium: Causes, Diagnosis, and Treatments

      18 citations, March 2016 in “Cosmetics”
      Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.
      Lisinopril-Induced Alopecia: A Case Report

      research Lisinopril-Induced Alopecia: A Case Report

      8 citations, June 2016 in “Journal of Pharmacy Practice”
      Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.
      The Inflammatory Component of Androgenetic Alopecia

      research The Inflammatory Component of Androgenetic Alopecia

      3 citations, November 2021 in “Journal of The American Academy of Dermatology”
      Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.
      Local Anesthesia Techniques in Hair Restoration Surgery

      research Local Anesthesia Techniques in Hair Restoration Surgery

      3 citations, May 2016 in “Journal of Cutaneous Medicine and Surgery”
      The document suggests using small syringes, distraction techniques, topical anesthetics, and specific drugs to ensure a pain-free experience during hair restoration surgery.
      Letters to Dermatology

      research Letters to Dermatology

      2 citations, January 1998 in “Dermatology”
      Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.
      Alopecia: From Clinic to Preclinic and Back

      research Alopecia: From Clinic to Preclinic and Back

      1 citations, December 2019 in “Formuly farmacii”
      Many people suffer from hair loss, which is caused by a disruption in hair growth, and there is a need for personalized treatments and new drugs.